Kangxian Luo

1.4k total citations
41 papers, 1.2k citations indexed

About

Kangxian Luo is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Kangxian Luo has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hepatology, 31 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Kangxian Luo's work include Hepatitis C virus research (32 papers), Hepatitis B Virus Studies (31 papers) and Liver Disease Diagnosis and Treatment (14 papers). Kangxian Luo is often cited by papers focused on Hepatitis C virus research (32 papers), Hepatitis B Virus Studies (31 papers) and Liver Disease Diagnosis and Treatment (14 papers). Kangxian Luo collaborates with scholars based in China, United Kingdom and United States. Kangxian Luo's co-authors include Bartholomew M. Sefton, Jinlin Hou, George Lau, Peter Karayiannis, Jenny Waters, Yuming Wang, Cihan Yurdaydın, Patrick Marcellin, Philip McCloud and Patrizia Farci and has published in prestigious journals such as Molecular and Cellular Biology, Hepatology and Journal of General Virology.

In The Last Decade

Kangxian Luo

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kangxian Luo China 14 917 862 187 122 82 41 1.2k
Motoko Nagano‐Fujii Japan 22 799 0.9× 846 1.0× 218 1.2× 130 1.1× 69 0.8× 38 1.3k
L. Vitvitski France 18 1.0k 1.1× 984 1.1× 109 0.6× 215 1.8× 87 1.1× 46 1.4k
V. Lamonaca Italy 8 725 0.8× 924 1.1× 333 1.8× 83 0.7× 54 0.7× 12 1.1k
Sangeetha Vijaysri United States 7 341 0.4× 278 0.3× 194 1.0× 86 0.7× 49 0.6× 7 657
Nicole Krieger Germany 6 1.0k 1.1× 1.3k 1.6× 148 0.8× 144 1.2× 168 2.0× 6 1.5k
Robert J. Durso United States 10 404 0.4× 450 0.5× 253 1.4× 131 1.1× 59 0.7× 14 915
Christiane Brohm Germany 7 403 0.4× 439 0.5× 146 0.8× 174 1.4× 42 0.5× 7 674
Susana de Lucas Spain 11 306 0.3× 316 0.4× 70 0.4× 74 0.6× 104 1.3× 13 591
Shunichi Okada Japan 10 942 1.0× 1.2k 1.4× 32 0.2× 128 1.0× 93 1.1× 14 1.3k
Patrick Maillard France 13 368 0.4× 401 0.5× 113 0.6× 66 0.5× 17 0.2× 22 665

Countries citing papers authored by Kangxian Luo

Since Specialization
Citations

This map shows the geographic impact of Kangxian Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kangxian Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kangxian Luo more than expected).

Fields of papers citing papers by Kangxian Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kangxian Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kangxian Luo. The network helps show where Kangxian Luo may publish in the future.

Co-authorship network of co-authors of Kangxian Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Kangxian Luo. A scholar is included among the top collaborators of Kangxian Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kangxian Luo. Kangxian Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lü, Ning, Xuan Huang, Ying Xu, et al.. (2019). Boosting of Hepatitis B Virus-Specific T Cell Responses After Pegylated-Interferon-α-2a Therapy for Hepatitis B e Antigen-Positive Pediatric Patients. Journal of Interferon & Cytokine Research. 39(12). 740–751. 6 indexed citations
3.
Luo, Kangxian, et al.. (2007). [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].. PubMed. 87(26). 1840–3.
4.
Li, Minghui, Yao Xie, Hui Zhao, et al.. (2006). [Retreatment with interferon of relapsed chronic hepatitis C patients].. PubMed. 14(1). 3–6. 1 indexed citations
5.
Luo, Kangxian, et al.. (2005). Preliminary identification and analysis of point mutations correlated with response to interferon-alpha in hepatitis B virus post-transcriptional regulatory elements.. PubMed. 118(1). 56–61. 1 indexed citations
6.
Sun, Jian, Zhanhui Wang, Shiwu Ma, et al.. (2005). Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: A single center experience. Journal of Medical Virology. 75(3). 391–398. 26 indexed citations
7.
Xie, Yao, Dao-zhen Xu, Zhi‐Meng Lu, et al.. (2005). Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trial.. PubMed. 4(2). 213–9. 18 indexed citations
8.
Yu, Yuecheng, Jinjun Chen, Jian Sun, et al.. (2005). [A comparison of clinical and virological characteristics of 1686 cases of HBeAg-negative and HBeAg-positive chronic hepatitis B].. PubMed. 44(9). 648–51. 6 indexed citations
9.
Luo, Kangxian, Zhihua Liu, Haitang He, et al.. (2004). The Putative Recombination of Hepatitis B Virus Genotype B with Pre-C/C Region of Genotype C. Virus Genes. 29(1). 31–41. 21 indexed citations
10.
Xie, Yao, Dao-zhen Xu, Zhi‐Meng Lu, et al.. (2004). [The influence of HCV genotype on the IFN treatment of patients with chronic hepatitis C].. PubMed. 12(2). 72–5. 3 indexed citations
11.
Luo, Kangxian, Haitang He, Zhihua Liu, et al.. (2002). Novel variants related to TT virus distributed widely in China*. Journal of Medical Virology. 67(1). 118–126. 37 indexed citations
12.
Liu, Zhihua, et al.. (2002). Novel TTV variants isolated in an epidemic of hepatitis of unknown etiology. Journal of Medical Virology. 67(1). 113–117. 6 indexed citations
13.
Yang, Jie, et al.. (2002). [Application of multiplex PCR in genotyping of hepatitis B virus prevailing in Guangdong Province of China].. PubMed. 22(8). 707–9. 2 indexed citations
14.
Li, Yan, Jinlin Hou, Yabin Guo, et al.. (2001). Determination and analysis of complete nucleotide sequence of Chinese genotype D hepatitis B virus: the first report.. PubMed. 21(11). 848–851. 1 indexed citations
15.
Hou, Jinlin, Z. Wang, Jin Cheng, et al.. (2001). Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology. 34(5). 1027–1034. 164 indexed citations
16.
Hou, Jinlin, et al.. (1999). T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients. Liver International. 19(5). 411–417. 34 indexed citations
17.
Hou, Jinlin, et al.. (1995). A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology. 21(2). 273–278. 84 indexed citations
18.
Luo, Kangxian, et al.. (1992). Correlation Between the Prevalence of Serum HBV DNA and Immunoserologic HBV Markers in the Subjects with or without Hepatitis. Immunological Investigations. 21(3). 275–281. 6 indexed citations
19.
Luo, Kangxian, et al.. (1991). Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. Journal of Medical Virology. 35(1). 55–59. 57 indexed citations
20.
Luo, Kangxian & Bartholomew M. Sefton. (1990). Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site.. Molecular and Cellular Biology. 10(10). 5305–5313. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Motoko Nagano‐Fujii Breakdown of academic impact, for papers by L. Vitvitski Breakdown of academic impact, for papers by V. Lamonaca Breakdown of academic impact, for papers by Sangeetha Vijaysri Breakdown of academic impact, for papers by Nicole Krieger Breakdown of academic impact, for papers by Robert J. Durso Breakdown of academic impact, for papers by Christiane Brohm Breakdown of academic impact, for papers by Susana de Lucas Breakdown of academic impact, for papers by Shunichi Okada Breakdown of academic impact, for papers by Patrick Maillard
Rankless by CCL
2026